雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Significance and Response to APOE Genetic Testing in the Anti-amyloid-β Therapy Era Takayoshi Shimohata 1 1Department of Neurology, Gifu University Graduate School of Medicine Keyword: アルツハイマー病 , APOE遺伝子検査 , 抗アミロイドβ療法 , レカネマブ , アミロイド関連画像異常 , ARIA , Alzheimer's disease , APOE genetic testing , anti-amyloid-β therapy , lecanemab pp.1029-1034
Published Date 2024/9/1
DOI https://doi.org/10.11477/mf.1416202728
  • Abstract
  • Look Inside
  • Reference

Abstract

Conventionally, APOE genetic testing has not been recommended as a component of the standard diagnostic and management practices for Alzheimer's disease. However, recent research highlights the importance of this test, particularly for assessment of the safety profile of anti-amyloid-β therapies. Therefore, the current United States guidelines for the administration of lecanemab explicitly advise APOE genetic testing. However, integration of this testing into clinical practice is associated with many clinical, ethical, legal, and economic challenges. It is important to initiate comprehensive discussions to address these multifaceted issues in Japan.


Copyright © 2024, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有